Mengxi Ge

406 total citations
15 papers, 281 citations indexed

About

Mengxi Ge is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mengxi Ge has authored 15 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mengxi Ge's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (7 papers) and Brain Metastases and Treatment (5 papers). Mengxi Ge is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (7 papers) and Brain Metastases and Treatment (5 papers). Mengxi Ge collaborates with scholars based in China. Mengxi Ge's co-authors include Xiaohua Liang, Qiong Zhan, Ruofan Huang, Xinli Zhou, Li Liao, Xiaoyu Ji, Kun Chen, Lin Hao, Jingwei Jiang and Dong Li and has published in prestigious journals such as Genomics, BMC Cancer and Frontiers in Oncology.

In The Last Decade

Mengxi Ge

13 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengxi Ge China 8 183 144 108 97 30 15 281
Clare Keddy United States 5 147 0.8× 114 0.8× 61 0.6× 114 1.2× 14 0.5× 6 224
Amaya Gascó Spain 7 164 0.9× 159 1.1× 95 0.9× 98 1.0× 9 0.3× 18 248
Michela Palleschi Italy 9 133 0.7× 189 1.3× 75 0.7× 75 0.8× 41 1.4× 46 281
Morana Vojnic United States 7 165 0.9× 132 0.9× 45 0.4× 129 1.3× 21 0.7× 24 276
Chelsea Jenkins United States 4 118 0.6× 105 0.7× 60 0.6× 114 1.2× 12 0.4× 5 216
Fouad Alchami United Kingdom 6 180 1.0× 180 1.3× 76 0.7× 135 1.4× 37 1.2× 8 321
M. Campone France 8 86 0.5× 128 0.9× 44 0.4× 79 0.8× 32 1.1× 21 217
Mónica Garzón Spain 5 150 0.8× 105 0.7× 117 1.1× 153 1.6× 6 0.2× 6 263
Margherita Carucci United Kingdom 5 195 1.1× 165 1.1× 93 0.9× 133 1.4× 46 1.5× 7 301
Manuel Ramos Vázquez Spain 6 92 0.5× 129 0.9× 56 0.5× 106 1.1× 36 1.2× 18 210

Countries citing papers authored by Mengxi Ge

Since Specialization
Citations

This map shows the geographic impact of Mengxi Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengxi Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengxi Ge more than expected).

Fields of papers citing papers by Mengxi Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengxi Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengxi Ge. The network helps show where Mengxi Ge may publish in the future.

Co-authorship network of co-authors of Mengxi Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Mengxi Ge. A scholar is included among the top collaborators of Mengxi Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengxi Ge. Mengxi Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yao, Rongrong, Quanbao Zhang, Mengxi Ge, et al.. (2025). The safety and efficacy of atezolizumab for recurrent primary liver cancer after liver transplantation. Discover Oncology. 16(1). 553–553. 1 indexed citations
2.
3.
Jiang, Rongrong, Hui Zhou, Mengxi Ge, et al.. (2024). PHF12 regulates HDAC1 to promote tumorigenesis via EGFR/AKT signaling pathway in non-small cell lung cancer. Journal of Translational Medicine. 22(1). 689–689.
4.
Wang, Qijun, Mengxi Ge, Jie Xu, et al.. (2023). Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report. Frontiers in Oncology. 13. 1042417–1042417. 1 indexed citations
5.
Ge, Mengxi, Shicheng Yu, Chunzhu Chen, et al.. (2023). Correlation between immunotherapy biomarker PD-L1 expression and genetic alteration in patients with non-small cell lung cancer. Genomics. 115(4). 110648–110648. 4 indexed citations
6.
Huang, Ruofan, Xiao Xu, Dong Li, et al.. (2019). Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases. Targeted Oncology. 14(3). 343–350. 44 indexed citations
7.
Zhan, Qiong, Feng Miao, Ruofan Huang, et al.. (2019). Efficacy and safety of bevacizumab combined with chemotherapy in symptomatic brain metastases from lung adenocarcinoma: a retrospective analysis. Journal of Thoracic Disease. 11(11). 4725–4734. 6 indexed citations
8.
9.
Liao, Li, Mengxi Ge, Qiong Zhan, et al.. (2019). Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non‐small cell lung cancer patients. Thoracic Cancer. 10(5). 1203–1212. 15 indexed citations
10.
Huang, Ruofan, Mengxi Ge, Xinli Zhou, et al.. (2018). Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis. Cancer Biotherapy and Radiopharmaceuticals. 34(2). 128–133. 5 indexed citations
11.
Liao, Li, Mengxi Ge, Qiong Zhan, et al.. (2018). PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways. International Journal of Biological Sciences. 15(1). 183–194. 32 indexed citations
12.
Liao, Li, Xiaoyu Ji, Mengxi Ge, et al.. (2018). Characterization of genetic alterations in brain metastases from non‐small cell lung cancer. FEBS Open Bio. 8(9). 1544–1552. 26 indexed citations
13.
Hao, Lin, et al.. (2018). TBL1XR1 as a potential therapeutic target that promotes epithelial‑mesenchymal transition in lung squamous cell carcinoma. Experimental and Therapeutic Medicine. 17(1). 91–98. 12 indexed citations
14.
Ge, Mengxi, et al.. (2017). High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases. Journal of Neuro-Oncology. 135(2). 413–418. 92 indexed citations
15.
Zhan, Qiong, Ruofan Huang, Xiaohua Liang, et al.. (2014). FRAS1 knockdown reduces A549 cells migration and invasion through downregulation of FAK signaling.. PubMed. 7(7). 1692–7. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clare Keddy Breakdown of academic impact, for papers by Amaya Gascó Breakdown of academic impact, for papers by Michela Palleschi Breakdown of academic impact, for papers by Morana Vojnic Breakdown of academic impact, for papers by Chelsea Jenkins Breakdown of academic impact, for papers by Fouad Alchami Breakdown of academic impact, for papers by M. Campone Breakdown of academic impact, for papers by Mónica Garzón Breakdown of academic impact, for papers by Margherita Carucci Breakdown of academic impact, for papers by Manuel Ramos Vázquez
Rankless by CCL
2026